SCHEMBL6715903

SCHEMBL6715903

Cc1ccc(N(C(N)=O)c2ncc(C(C)C)s2)cc1O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.35
PTGS1 P23219 1/20 0.35
CACNA1C Q13936 1/20 0.35
ALOX5 P09917 9/20 0.35
CDK2 P24941 7/20 0.35
CCNE1 P24864 6/20 0.35
CDK5 Q00535 6/20 0.35
CCNT1 O60563 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CDK1 P06493 1/20 0.32
CDK4 P11802 1/20 0.32
CCNB1 P14635 1/20 0.32
CCNA2 P20248 1/20 0.32
CCND1 P24385 1/20 0.32
CDK7 P50613 1/20 0.32
CDK9 P50750 1/20 0.32
CCNH P51946 1/20 0.32
MNAT1 P51948 1/20 0.32
CDK5R1 Q15078 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7257113 0.85 CDK2 (0.38) ALOX5CDK2CCNE1CDK5CCNT1
SCHEMBL27551086 0.83 CCNE1 (0.36) ALOX5CDK2CCNE1CDK5CCNT1
SCHEMBL7848231 0.82 CCNE1 (0.38) ALOX5CDK2CCNE1CDK5CCNT1
SCHEMBL27570619 0.82 CDK2 (0.38) ALOX5CDK2CCNE1CDK5CCNT1
SCHEMBL27572548 0.82 CDK2 (0.38) ALOX5CDK2CCNE1CDK5CCNT1
SCHEMBL6710801 0.81 KDM4E (0.36) ALOX5CDK2CCNE1CDK5MLYCD
SCHEMBL27574287 0.81 CCNE1 (0.37) ALOX5CDK2CCNE1CDK5CCNT1
SCHEMBL6710898 0.81 MLYCD (0.38) ALOX5CDK2CCNE1CDK5CCNT1
SCHEMBL6711707 0.81 MLYCD (0.47) ALOX5CDK2CCNE1CDK5CCNT1
SCHEMBL7849419 0.81 CCNE1 (0.36) ALOX5CDK2CCNE1CDK5CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157827-A1 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents PEVARELLO PAOLO (IT) 2004-08-12 US disclosed
US-20030187040-A1 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents PHARMACIA & UPJOHN SPA (IT) 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187040-A1 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents UCK2, ULK3, CDK2 TRPA1 3863/4885PTGS1 2424/4885CACNA1C 4577/4885
US-20040157827-A1 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents UCK2, ULK3, CDK2 TRPA1 3863/4885PTGS1 2424/4885CACNA1C 4577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.